The Small Animal Imaging Shared Resource (SAISR) is a new facility that was started as an SR in Development at our last competing renewal, and established in 2012 as a full-fledged SR. The goal is to provide users with access to anatomical and functional imaging modalities, and provide scientific, technical, and administrative support for imaging experiments. Current imaging modalities include optical imaging (fluorescent and luminescent), optical/XR, high-resolution ultrasound, and MRI. Optical imaging is carried out on a Caliper IVIS Spectrum instrument, which provides whole-animal 2D, 3D, and kinetic imaging capabilities for mice with engineered or injected optical reporters. A Lumina II XR instrument was recently purchased to provide co-registered optical and XR imaging. Ultrasound is performed using a Vevo 2100 Instrument with 2D, 3D, power Doppler, color Doppler, RF mode, and non-linear contrast mode, along with an image-guided injection mount. MRI Is performed using a Bruker ICON benchtop (IT) system. Dr. Kenneth Olive serves as Director of the Small Animal Imaging SR. Dr. Olive has 8 years of experience using ultrasound for cancer research in mice. The facility is managed by Steven Sastra, who has 23 years of biomedical research experience, and nearly a decade of experience working with small animal imaging modalities, including ultrasound, optical, and micro CT imaging. Daily operations are overseen by Raymond Chang who has over a decade of experience with MRI, PET, SPECT, CT, ultrasound, and optical imaging modalities. Even though this SR has only been full-fledged for 2 years, it is already heavily used by more than 20 HICCC Principal Investigators. Our next stage in expanding this facility entails renovation of the barrier facility to create more space, followed by the addition of a PET-CT instrument and installation of a high-field MRI. The total operating budget of the facility is $236,389 of which we are requesting $38,889 from the CCSG.

Public Health Relevance

Over the past two decades, many of the seminal achievements in cancer research were made possible through the use of mouse models of cancer. In recent years, the hard-won investment in basic cancer science has made possible an increasing focus on translational studies that are designed to evaluate new drugs for their ability to treat or cure established tumors. Just as imaging is used to monitor the effects of drug treatment on human patients, small animal imaging has become an indispensable technology for preclinical studies in mouse models of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-40
Application #
8753129
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2019-06-30
Budget Start
2014-07-17
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$55,462
Indirect Cost
$20,798
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Wu, Hui-Chen; Do, Catherine; Andrulis, Irene L et al. (2018) Breast cancer family history and allele-specific DNA methylation in the legacy girls study. Epigenetics 13:240-250
Brescia, Paola; Schneider, Christof; Holmes, Antony B et al. (2018) MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. Cancer Cell 34:453-465.e9
Tzoneva, Gannie; Dieck, Chelsea L; Oshima, Koichi et al. (2018) Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature 553:511-514
Sitko, Austen A; Kuwajima, Takaaki; Mason, Carol A (2018) Eye-specific segregation and differential fasciculation of developing retinal ganglion cell axons in the mouse visual pathway. J Comp Neurol 526:1077-1096

Showing the most recent 10 out of 331 publications